A detailed history of Cullen/Frost Bankers, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 323,526 shares of MRK stock, worth $30.6 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
323,526
Previous 321,525 0.62%
Holding current value
$30.6 Million
Previous $36.5 Million 11.85%
% of portfolio
0.45%
Previous 0.5%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$96.31 - $114.76 $192,716 - $229,634
2,001 Added 0.62%
323,526 $32.2 Million
Q3 2024

Nov 06, 2024

BUY
$111.15 - $128.97 $310,441 - $360,213
2,793 Added 0.88%
321,525 $36.5 Million
Q2 2024

Aug 05, 2024

SELL
$123.8 - $132.96 $1.09 Million - $1.17 Million
-8,772 Reduced 2.68%
318,732 $39.5 Million
Q1 2024

May 10, 2024

SELL
$113.24 - $131.95 $526,113 - $613,039
-4,646 Reduced 1.4%
327,504 $43.2 Million
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $1.65 Million - $1.8 Million
-16,512 Reduced 4.74%
332,150 $36.2 Million
Q3 2023

Nov 02, 2023

BUY
$102.95 - $114.33 $183,045 - $203,278
1,778 Added 0.51%
348,662 $35.9 Million
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $543 - $591
5 Added 0.0%
346,884 $40 Million
Q1 2023

May 05, 2023

SELL
$102.94 - $114.86 $788,726 - $880,057
-7,662 Reduced 2.16%
346,879 $36.9 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $1.81 Million - $2.32 Million
20,669 Added 6.19%
354,541 $39.3 Million
Q3 2022

Nov 07, 2022

BUY
$84.53 - $94.96 $472,691 - $531,016
5,592 Added 1.7%
333,872 $28.8 Million
Q2 2022

Aug 05, 2022

BUY
$83.49 - $94.64 $301,148 - $341,366
3,607 Added 1.11%
328,280 $30 Million
Q1 2022

May 09, 2022

SELL
$73.51 - $82.4 $377,326 - $422,959
-5,133 Reduced 1.56%
324,673 $26.7 Million
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $1.97 Million - $2.47 Million
-27,303 Reduced 7.65%
329,806 $25.3 Million
Q3 2021

Nov 04, 2021

SELL
$71.68 - $78.83 $2.02 Million - $2.23 Million
-28,229 Reduced 7.33%
357,109 $26.8 Million
Q2 2021

Aug 05, 2021

BUY
$70.31 - $77.77 $878,664 - $971,891
12,497 Added 3.35%
385,338 $30 Million
Q1 2021

May 05, 2021

SELL
$68.86 - $81.11 $6.43 Million - $7.58 Million
-93,435 Reduced 20.04%
372,841 $28.8 Million
Q4 2020

Feb 08, 2021

SELL
$71.77 - $79.65 $1.71 Million - $1.9 Million
-23,823 Reduced 4.86%
466,276 $38.2 Million
Q3 2020

Nov 05, 2020

SELL
$73.18 - $82.95 $1.49 Million - $1.69 Million
-20,363 Reduced 3.99%
490,099 $40.7 Million
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $4.82 Million - $5.48 Million
68,438 Added 15.48%
510,462 $39.5 Million
Q1 2020

May 01, 2020

BUY
$63.36 - $87.82 $548,634 - $760,433
8,659 Added 2.0%
442,024 $34 Million
Q4 2019

Feb 06, 2020

SELL
$77.58 - $87.54 $1.9 Million - $2.14 Million
-24,439 Reduced 5.34%
433,365 $39.4 Million
Q3 2019

Nov 01, 2019

BUY
$76.08 - $82.93 $9.93 Million - $10.8 Million
130,484 Added 39.86%
457,804 $38.6 Million
Q2 2019

Aug 01, 2019

BUY
$69.84 - $81.59 $530,434 - $619,676
7,595 Added 2.38%
327,320 $27.5 Million
Q1 2019

Apr 30, 2019

BUY
$69.58 - $79.36 $1.81 Million - $2.06 Million
25,983 Added 8.85%
319,725 $26.5 Million
Q4 2018

Feb 06, 2019

BUY
$65.24 - $75.71 $10,373 - $12,037
159 Added 0.05%
293,742 $22.4 Million
Q3 2018

Oct 29, 2018

BUY
$57.69 - $67.84 $3.44 Million - $4.04 Million
59,599 Added 25.47%
293,583 $20.8 Million
Q2 2018

Jul 27, 2018

BUY
$50.83 - $59.72 $2.78 Million - $3.27 Million
54,726 Added 30.53%
233,984 $14.2 Million
Q1 2018

May 11, 2018

SELL
$50.96 - $59.23 $1.16 Million - $1.34 Million
-22,678 Reduced 11.23%
179,258 $9.76 Million
Q4 2017

Jan 31, 2018

SELL
$51.62 - $61.64 $809,143 - $966,207
-15,675 Reduced 7.2%
201,936 $11.4 Million
Q3 2017

Nov 02, 2017

BUY
$58.67 - $63.13 $12.8 Million - $13.7 Million
217,611
217,611 $13.9 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $240B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.